| Nursecore Of Tucson | |
| 2980 North Campbell, Suite 160, Tucson, Arizona 85719 | |
| (520) 791-2300 | |
| Not Available |
| Name | Nursecore Of Tucson |
|---|---|
| Location | 2980 North Campbell, Suite 160, Tucson, Arizona |
| Certified By | Medicare |
| Services Offered | Nursing Care Home Health Aide |
| Medicare ID | 37118 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 85712, 85719, 85737 |
| NPI Number | 1376585869 |
| Organization Name | NURSECORE MANAGEMENT SERVICES LLC |
| Doing Business As | NURSECORE OF TUCSON |
| Address | 2980 N Campbell Ave, Suite 160, Tucson, AZ 85719 |
| Phone Number | 520-791-2300 |
News Archive
The Multiple Myeloma Research Foundation and Astellas Pharma Global Development, Inc. today announced that they have entered into a joint collaboration for the clinical development of OSI-906 in patients with relapsed multiple myeloma.
Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.
As a recent Newsweek article states, "it's hardly clear that there actually is an obesity epidemic, or that fat people are at greater risk of death than people of normal weight, or that weight loss—relentlessly promoted by public-health officials as the solution to America's weight problem—is an attainable goal at all."
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
Even for those without a heart condition, it's a peculiar feeling when your heart "races" in response to stress.
› Verified 6 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
The Multiple Myeloma Research Foundation and Astellas Pharma Global Development, Inc. today announced that they have entered into a joint collaboration for the clinical development of OSI-906 in patients with relapsed multiple myeloma.
Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.
As a recent Newsweek article states, "it's hardly clear that there actually is an obesity epidemic, or that fat people are at greater risk of death than people of normal weight, or that weight loss—relentlessly promoted by public-health officials as the solution to America's weight problem—is an attainable goal at all."
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
Even for those without a heart condition, it's a peculiar feeling when your heart "races" in response to stress.
› Verified 6 days ago
News Archive
The Multiple Myeloma Research Foundation and Astellas Pharma Global Development, Inc. today announced that they have entered into a joint collaboration for the clinical development of OSI-906 in patients with relapsed multiple myeloma.
Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.
As a recent Newsweek article states, "it's hardly clear that there actually is an obesity epidemic, or that fat people are at greater risk of death than people of normal weight, or that weight loss—relentlessly promoted by public-health officials as the solution to America's weight problem—is an attainable goal at all."
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
Even for those without a heart condition, it's a peculiar feeling when your heart "races" in response to stress.
› Verified 6 days ago
Interim Healthcare Location: 5055 East Broadway, Suite D-104, Tucson, Arizona 85711 Ratings: Phone: (520) 747-1800 | |
Kindred At Home Location: 5255 East Williams Circle, Suite 6400, Tucson, Arizona 85711 Ratings: Phone: (520) 731-1333 | |
Dependable Home Health, Inc Location: 1121 North El Dorado Place, Suite 350, Tucson, Arizona 85715 Ratings: Phone: (520) 721-3822 | |
Intrepid Usa Healthcare Services Location: 1 West Wetmore Road, Suite 203, Tucson, Arizona 85705 Ratings: Phone: (529) 742-0272 | |
Nursecore Of Tucson Location: 2980 North Campbell, Suite 160, Tucson, Arizona 85719 Ratings: NA Phone: (520) 791-2300 | |
Nsi Nursing Service, Inc. Location: 3075 North Swan Road, Tucson, Arizona 85712 Ratings: NA Phone: (520) 731-1117 |